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The Impact of Demographic, Social, and Environmental Factors on
the Development of Steroid-Responsive Meningitis-Arteritis
(SRMA) in the United Kingdom
J.H. Rose, M. Kwiatkowska, E.R. Henderson, N. Granger, J.K. Murray, and T.R. Harcourt-Brown
Background: Steroid-responsive meningitis-arteritis (SRMA) is an inﬂammatory disease of dogs that is suspected to be
immune-mediated. The development of other immune-mediated diseases has been linked to vaccinations, time of the year,
geographic location, sex, neuter status, and breed.
Hypothesis/Objectives: To identify if the development of SRMA is associated with time of year, vaccination, geo-
graphic location, sex, neuter status, and breed.
Animals: Sixty SRMA cases and 180 controls, all ≤24 months of age and matched for year of presentation, from a
referral hospital population in the United Kingdom.
Methods: Retrospective case-control study with unconditional logistic regression analysis.
Results: Beagles (P = .001), Border Collies (P = .001), Boxers (P = .032), Jack Russell Terriers (P = .001), Weimara-
ners (P = .048), and Whippets (P < .001) had signiﬁcantly greater odds of developing SRMA in this population of dogs.
Vaccination, time of year, geographic category, sex, and neuter status did not increase the odds of developing SRMA.
Conclusions and Clinical Importance: Only breed increased the odds of developing SRMA. It would be prudent to
investigate the genetics of the identiﬁed breeds to help elucidate the etiopathogenesis of SRMA.
Key words: Aseptic meningitis; Necrotizing vasculitis.
Steroid-responsive meningitis-arteritis (SRMA) is awell-recognized inﬂammatory disease of dogs. One
study documented a prevalence of 0.6% of all cases
and 1.6% of neurologic consults at a referral hospital
in the United Kingdom.1
SRMA can occur in any breed but Beagles, Boxers,
Bernese Mountain Dogs (BMD), Nova Scotia Duck
Tolling Retrievers (NSDTR), Weimaraners, and Eng-
lish Springer Spaniels1,2 seem to be predisposed. No
sex predisposition exists for the disease. The age of
onset of SRMA is 3 months to 9 years, but 1 study
suggested resistance to relapse develops at approxi-
mately 2 years of age.3
Dogs with SRMA have a waxing and waning
disease course characterized by episodic cervical hyper-
esthesia, obtundation, and pyrexia.2 Acute and chronic
forms of the disease exist.2 There is no deﬁnitive ante-
mortem test for SRMA and diagnosis is based on clin-
ical criteria, laboratory ﬁndings, exclusion of other
diseases,1 and response to corticosteroids.
The etiopathogenesis of SRMA is unknown, but an
immune-mediated process is suspected.2 An antigenic
stimulus is suspected to trigger SRMA but no infec-
tious or neoplastic triggers have been identiﬁed.2,3
Antigenic triggers have been identiﬁed for other
immune-mediated diseases, and infections, neoplasms,
drugs, and vaccinations have been implicated.4
The prevalence of some immune-mediated diseases
in dogs has been associated with time of year, breed,
sex, and neuter status.4 In humans, immune-mediated
conditions have been shown to have associations with
social factors, including geographic location.
The aim of this study was to determine if develop-
ment of SRMA was associated with time of year, vac-
cination, geographic location, sex, neuter status, or
breed. These results may identify factors for further
investigation that could help elucidate the etiopatho-
genesis of SRMA.
Materials and Methods
Dogs with the acute form of SRMA were identiﬁed by search-
ing records of cases presented to Langford Veterinary Services
between January 1, 2003, and December 31, 2012. Cases were
included if they had neck pain, obtundation, pyrexia, a cisternal
cerebrospinal ﬂuid (CSF) sample with neutrophilic pleocytosis
and no pathologic organisms on cytology, a CBC and serum
biochemistry proﬁle, normal orthogonal cervical radiographic
ﬁndings, and resolution of clinical signs after treatment with cor-
ticosteroids. Cases were excluded if they had neurologic deﬁcits
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in addition to neck pain and obtundation or if they were over
24 months of age at presentation.
Neck pain was deﬁned by a behavioral change or resistance to
movement when the cervical spine was manipulated laterally or
vertically. Obtundation was deﬁned as decreased response to
environmental stimuli. Pyrexia was deﬁned as a rectal tempera-
ture >102.5°F. Neutrophilic pleocytosis in CSF was deﬁned as a
total nucleated cell count (TNCC) >5 cells/lL and total protein
>25 mg/dL with >50% of the TNCC being neutrophils.
Three controls, matched for year of presentation, were selected
per SRMA case.5 Hospital numbers of controls were randomly
selected by using a computer program.a Patients were selected as
controls if they were dogs ≤24 months of age, had been referred
with clinical signs indicative of a pathologic process, had not
been diagnosed with SRMA, or if no diagnosis had been made,
did not have signs of neck pain, obtundation, or pyrexia. If the
selected patient failed to meet these criteria, the ascending and
then descending sequential hospital number was reviewed until a
control was identiﬁed.
Information regarding the date of onset of disease, time
between last vaccination and onset of disease, postal code, sex,
neuter status, and breed was recorded for all cases and controls.
The date of onset of disease was categorized by season: Spring
(March, April, and May), Summer (June, July, and August),
Autumn (September, October, and November), or Winter
(December, January, and February).
Time from vaccination to onset of disease was categorized as
≤6 weeks or >6 weeks. This time frame is commonly used when
investigating the association between vaccination and Guillain-
Barre syndrome.
Each postal code was used to generate metadata about urban
or rural indicators based on UK Census data.b Cases and con-
trols were assigned to 1 of 4 environmental categories: urban,
town and fringe, village, and hamlet with isolated dwelling.
Individual breeds were analyzed if they occurred at a fre-
quency ≥3 in the SRMA dataset or had been reported previously
to have an increased incidence of SRMA in other studies. All
other breeds were placed in 1 category labeled “other breeds.”
Normality was tested in cases and controls on age at onset of
disease by using a Shapiro-Wilk test with a software program.c
An unpaired 2-tailed t-test was performed to compare the age at
onset of disease between cases and controls by using a software
program.d
Univariable unconditional logistic regression analysis was per-
formed on the dataset for the variables season, vaccination date,
environmental category, sex, neuter status, and breed by using a
software program.c Variables with a univariable P < .2 were con-
sidered for inclusion in a multivariable model to allow for possi-
ble confounding. Variables with a P < .05 in the multivariable
model were considered signiﬁcant.
Results
Sixty SRMA cases met the inclusion and exclusion
criteria and therefore 180 controls were selected.
SRMA cases made up 0.37% of dogs referred to our
clinic (2003–2012).
The age of onset of disease data were normally dis-
tributed (Shapiro-Wilk, P < .001). The mean (standard
deviation) was 10.25 months (5.02) for SRMA cases
and 9.51 months (6.86) for controls. The means for
these groups were not signiﬁcantly diﬀerent (P = .44).
Univariable unconditional logistic regression did not
show signiﬁcantly increased odds of developing SRMA
with the variables of season, vaccination date, environ-
mental category, or sex (Table 1). Multivariable
unconditional logistic regression showed Beagles, Bor-
der collies, Boxers, Jack Russell Terriers (JRT), Wei-
maraners, and Whippets had signiﬁcantly increased
odds of developing SRMA compared to “other
breeds.” Neuter status did not have a signiﬁcant eﬀect
on the odds of developing SRMA (Table 1).
Discussion
The odds of developing SRMA were signiﬁcantly
increased for Beagles, Border Collies, Boxers, JRT,
Weimaraners, and Whippets in this population of
dogs. No other associations, including time of year,
vaccination, geographic location, sex, and neuter sta-
tus, were found. Other breeds may have an increased
probability of developing SRMA that was not identi-
ﬁed in this study, because of type 2 statistical error,
associated with the limited number of dogs in this
investigated population.
Beagles and Weimaraners previously have been
reported to be overrepresented in studies of SRMA,2
whereas Boxers have been statistically proven to be
overrepresented.1 Our study supports these ﬁndings.
Jack Russell Terriers, Border Collies, and Whippets
have not previously been shown to be overrepresented
or to have increased odds of developing SRMA. These
breeds may be kept by owners whose lifestyle exposes
the dogs to an environmental trigger, or they may have
a genetic predisposition to develop SRMA that was not
previously identiﬁed because of smaller study sizes.
There is evidence to suggest a genetic predisposition to
various immune-mediated diseases in dogs. For exam-
ple, some breeds may be predisposed to hypoadrenocor-
ticism secondary to a mutation in genes associated with
the major histocompatability complex class II molecule
(MHC II).6,7 Given the link between MHC II and acti-
vated T cells8 and the presence of activated T cells in
SRMA,2 it may be worth investigating this link in the
breeds with increased odds of developing SRMA.
We did not demonstrate increased odds of develop-
ing SRMA in English Springer Spaniels, but another
study has statistically shown overrepresentation of this
breed.1 Nor did our study show any increased odds
for BMD and NSDTR to develop SRMA, although
overrepresentation of these breeds has been suspected.2
This may represent a geographic variation in intra-
breed susceptibility to SRMA, a variation in breed
popularity with location such that environmental fac-
tors may be inﬂuential, or type 2 statistical error.
Bitches and neutered dogs have been shown to be
more susceptible to immune-mediated hemolytic ane-
mia (IMHA)4 and immune-mediated thrombocytope-
nia (IMTP), leading to the hypothesis that androgen
hormones may be protective against immune-mediated
disease development. Sex and neuter status did not sig-
niﬁcantly aﬀect the odds of developing SRMA in our
study. Previous studies also have shown no relation of
sex to SRMA, making androgens unlikely to be
protective against SRMA.
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In IMHA and IMTP, an association between time
of year and onset of disease has been reported,4 lead-
ing to the suggestion that time of year may be linked
to exposure to infectious agents that trigger disease.
This ﬁnding has not been replicated in other studies of
IMHA or immune-mediated polyarthritis. There was
no increase in odds of developing SRMA in any sea-
son in our study suggesting that if an infectious trigger
exists for SRMA, its exposure is not inﬂuenced by sea-
son in the South West United Kingdom.
Links between immune-mediated diseases and vacci-
nation have been made, but controversy surrounds this
association.4 Vaccination within 6 weeks of the onset
of SRMA was not found to increase the odds of devel-
oping the disease in our study, suggesting vaccination
is unlikely to trigger SRMA.
There is some evidence that geographic factors can
aﬀect immune-mediated disease prevalence in humans
by inﬂuencing exposure to microbial agents, diet, and
stress. In dogs, geographic location can aﬀect exposure
to microbial agents such as ticks and leptospirosis.9,10
No increased probability was shown for environmental
category and SRMA in our study. There still could be
a link between geographic location and SRMA
because we may have investigated the wrong factors
and those that live in urban environments may travel
Table 1. Results of univariable and multivariable analysis.
Variable SRMA Cases (n) Controls (n) OR 95% CI P-Value
Univariable analysis
Season .78
Spring 18 (30%) 43 (24%) 1.00
Summer 12 (20%) 40 (22%) 0.72 0.31–1.67 .44
Autumn 16 (27%) 47 (26%) 0.81 0.37–1.79 .61
Winter 14 (23%) 50 (28%) 0.67 0.30–1.50 .33
Vaccination to onset of disease
<42 days 10 (17%) 38 (21%) 1.00
>42 days 50 (83%) 142 (79%) 1.34 0.62–2.88 .46
Environmental category
Urban 37 (62%) 97 (54%) 1.00 .77
Town 8 (13%) 29 (16%) 0.72 0.30–1.73 .47
Village 9 (15%) 31 (17%) 0.76 0.33–1.75 .52
Hamlet 6 (10%) 23 (13%) 0.68 0.26–1.81 .45
Sex
Male 34 (57%) 100 (56%) 1.00
Female 26 (43%) 80 (44%) 0.96 0.53–1.72 .88
Neutering status
Entire 39 (65%) 133 (74%) 1.00
Neutered 21 (35%) 47 (26%) 1.52 0.82–2.85 .19
Breed <.001
Other breeds 21 (35%) 145 (81%) 1.00
Beagle 5 (8%) 3 (2%) 11.51 2.56–51.72 .001
Border Collies 7 (12%) 7 (4%) 6.91 2.20–21.66 .001
Boxers 4 (7%) 6 (3%) 4.60 1.20–17.67 .026
JRT 7 (12%) 7 (4%) 6.91 2.20–21.66 .001
Weimaraners 2 (3%) 1 (1%) 13.81 1.20–159.02 .035
Whippets 11 (18%) 2 (1%) 37.98 7.86–183.38 <.001
BMD 0 (0%) 1 (1%) 0.00 0.00– 1.00
English Springer Spaniels 2 (3%) 8 (4%) 1.73 0.34–8.69 .51
NSDTR 1 (2%) 0 (0%) 11150000000.00 0.00– 1.00
Multivariable analysis
Neutering status
Entire 39 (65%) 133 (74%) 1.00
Neutered 21 (35%) 47 (26%) 1.44 0.69–2.99 .33
Breed <.001
Other breeds 21 (35%) 145 (81%) 1.00
Beagle 5 (8%) 3 (2%) 11.67 2.58–52.72 .001
Border Collies 7 (12%) 7 (4%) 6.54 2.07–20.67 .001
Boxers 4 (7%) 6 (3%) 4.39 1.14–16.98 .032
JRT 7 (12%) 7 (4%) 6.54 2.07–20.67 .001
Weimaraners 2 (3%) 1 (1%) 12.04 1.03–141.55 .048
Whippets 11 (18%) 2 (1%) 38.97 8.03–189.03 <.001
BMD 0 (0%) 1 (1%) 0.00 0.00– 1.00
English Springer Spaniels 2 (3%) 8 (4%) 1.77 0.35–8.92 .49
NSDTR 1 (2%) 0 (0%) 12354280409.00 0.00– 1.00
n, number; OR, odds ratio; CI, conﬁdence interval.
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to exercise their dogs. We have not examined the Uni-
ted Kingdom as a whole and it may be that dogs in
particular sections of the country are prone to SRMA.
As such, it could be important to investigate this possi-
bility more extensively in the future.
The main limitation of this article was the number
of SRMA cases. To our knowledge, this number
exceeds the number of cases in any other published
study, but it limited the power of the study to detect
variables with small eﬀect sizes on the odds of devel-
oping SRMA. By using a posthoc power calculation
with a conﬁdence interval of 95%, power 80%, and
exposure of control to the variables under investiga-
tion at 25% (selected given the assumption of equal
distribution of cases throughout the 4 seasons), the
minimum change in odds ratio (OR) that could be
detected was 2.4 (obtained by using a software pro-
gram assuming Fleiss’ calculation).e To detect smaller
changes in OR, we could have included more SRMA
cases. We could have allowed cases over 24 months of
age (n = 2), those with other neurologic signs (n = 4),
and those with mixed or mononuclear pleocytosis
(n = 12) because these ﬁndings have been described
previously with SRMA.2 We were concerned that by
including these cases we may have included other
inﬂammatory meningioencephalitides.1
We conclude that only breed aﬀected the odds of
developing SRMA in this population of dogs in the
South West United Kingdom. We cannot refute the
possibility of other breeds being predisposed to
SRMA. It is highly likely given the immune-mediated
nature of SRMA that multiple factors contribute to
the etiopathogenesis of the disease. This study has not
excluded other tested or untested environmental,
social, or demographic factors being involved in
SRMA, but given its ﬁndings and the fact that previ-
ous studies have failed to identify infectious or neo-
plastic triggers for SRMA, it would seem prudent to
investigate the genetics of the breeds with increased
odds to try and elucidate the pathogenesis of SRMA.
Such studies may lead to the development of a genetic
test that could identify individuals susceptible to
SRMA and allow a breeding program to eliminate
SRMA if other treatable triggers are not discovered.
Footnotes
a Research Randomizer, version 4.0, Urbaniak, G. C., & Plous,
S. (2013) [cited 2013, Jan 01] Available from: http://www.ran-
domizer.org/
b Oﬃce for National Statistics, Postcode Directories. UK Data
Service Census © Crown Copyright 2006
c IBM SPSS Statistics for Windows, version 19.0, IBM Corp,
Armonk, NY,
d GraphPad Prism for Windows, version 5.00, GraphPad Soft-
ware, San Diego, CA
e EpiInfo 7 for Windows, version 7.1.2, Centers for Disease Con-
trol and Prevention, Atlanta, GA
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